Nanotechnology in Thoracic Surgery
David A. Mahvi, MD, Mark W. Grinstaff, PhD, Yolonda L. Colson, MD, PhD
Key Elements
Key Elements
Key Elements
- An array of nanotherapeutic delivery platforms are currently being investigated to provide novel therapeutic options for thoracic malignancies
- Multiple chemotherapeutic drugs and/or gene delivery via nanotechnology platforms demonstrate efficacy in pre-clinical and limited clinical studies
- New polymer formulations that improve biocompatibility and tumor targeting with stimuli-responsiveness are maximizing therapeutic efficacy and minimizing adverse effects
- Nanotheranostics is a new field combining diagnostic and therapeutic modalities that will expedite next-generation, personalized medicine
|
There's more to see -- the rest of this topic is available only to subscribers.
© 2026 The Society of Thoracic Surgeons and Unbound Medicine, Inc. All Rights Reserved.
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.